Katalin Tarczy-Hornoch

Title: Katalin Tarczy-Hornoch: Innovator in Calcium Channel Research

Introduction

Katalin Tarczy-Hornoch is a prominent inventor based in Berkeley, CA. She has made significant contributions to the field of biochemistry, particularly in the development of novel peptides that target voltage-gated calcium channels. With a total of 2 patents, her work has implications for various medical applications.

Latest Patents

Tarczy-Hornoch's latest patents include a groundbreaking voltage-gated calcium channel antagonist and method. This novel class of peptides selectively blocks class E voltage-gated calcium channels. The class is exemplified by HG peptides, such as HG-1, which is isolated from the venom-producing cells of the tarantula Hysterocrates gigas. The patents also disclose methods for producing blocking class E channels using these peptides. HG peptides have potential utility in inhibiting oxytocin release and can be used as anticonvulsants.

Career Highlights

Katalin Tarczy-Hornoch is currently associated with Elan Pharmaceuticals, Inc., where she continues her research and development efforts. Her innovative work has positioned her as a key figure in her field, contributing to advancements in medical science.

Collaborations

Throughout her career, Tarczy-Hornoch has collaborated with notable colleagues, including Robert W. Newcomb and Andrew L. Palma. These collaborations have further enriched her research and expanded the impact of her inventions.

Conclusion

Katalin Tarczy-Hornoch is a distinguished inventor whose work in voltage-gated calcium channels has the potential to revolutionize treatments in various medical fields. Her contributions continue to inspire innovation and progress in biochemistry.